Why the study?
Does the presence of hepatic steatosis on CCTA predict cardiovascular events in patients with suspected coronary artery disease?
Design
Editorial
Key result
Hepatic steatosis was an independent predictor of cardiac death, acute coronary syndrome, and late revascularization, enhancing risk discrimination over adverse CCTA findings.
Authors
Loading...
May refine CCTA risk models in observational data; hypothesis-generating and requires prospective validation before practice change.
Does the presence of hepatic steatosis on CCTA predict cardiovascular events in patients with suspected coronary artery disease?
Hepatic steatosis assessed during routine CCTA provides incremental prognostic value for cardiovascular events beyond coronary anatomy and traditional risk scores.
Antonopoulos et al. (2021) conducted an editorial in suspected coronary artery disease (n=1,148). Hepatic steatosis was evaluated on composite endpoint of cardiac death, acute coronary syndrome, and late revascularization. Hepatic steatosis was an independent predictor of cardiac death, acute coronary syndrome, and late revascularization, enhancing risk discrimination over adverse CCTA findings.